ÂÜÀòÂÒÂ×

Julie Wilson has a strong background in the pharmaceutical and biopharmaceutical industries. Julie began their career as a Senior Scientist at NPS Pharmaceuticals (previously Allelix Biopharmaceuticals) from June 1998 to August 2007. Julie then joined BioQuest Innovations as the Director of Pharmacology from October 2007 to July 2008. Following this, they worked at the Ontario Institute for Cancer Research, starting as a Senior Program Manager from September 2008 to July 2013. Julie then served as the Associate Director of the Drug Discovery Program from July 2013 to May 2015 and subsequently as the Associate Director of PanCuRx, Translational Research Initiative in Pancreatic Cancer from May 2015 onwards.

Julie Wilson's education history includes a B.Sc. (Hons) degree in Pharmacology from the University of Aberdeen, which they obtained from 1985 until 1989. Julie further pursued their academic journey at the University of Toronto, where they obtained a Ph.D. in Pharmacology from 1990 to 1996.